PitchBook News - VC looks for sunnier skies

Female founders' strong finish to 2023; semiconductors ride a generative AI wave; auto commerce returns lead public mobility tech
Read online | Don't want to receive these emails? Manage your subscription.
PitchBook
Log in
The Daily Pitch: VC
January 11, 2024
The Daily Pitch is powered by PitchBook’s industry-defining research and best-in-class data
In today's Daily Pitch, you'll find:
 
Today's Top Stories  
VC looks for sunnier skies amid the clouds
Venture capital has had a tough 12 months. But despite a $71.6 billion drop in funding for the asset class compared to 2022—more than $88 billion if you leave out OpenAI and Anthropic's behemoth rounds—sunnier skies may be ahead.

VC deal count was still higher in Q4 2023 than in any quarter in the pre-2020 days, while public markets finished up for the year, according to the latest PitchBook-NVCA Venture Monitor, sponsored by J.P. Morgan, Dentons and Deloitte.

On the one hand, the IPO backlog keeps lengthening. On the other, the market is awash with dry powder, and many expect that economic uncertainty will lessen, bringing the market back into a stable state.
read it now
 
Share: Email LinkedIn Twitter Facebook
3 takeaways from VC funding for female founders
(Joey Schaffer/PitchBook News)
Female founders ended 2023 on a strong note as the year closed with the third-highest amount of venture capital raised for female-founded or co-founded startups on record, according to PitchBook's US VC Female Founders Dashboard.

Companies with at least one female founder raised about $32.7 billion in VC funding across 3,230 rounds in 2023, while startups with exclusively female founders garnered $2.8 billion over 867 deals. But a disparity exists, with more capital going to mixed-founder teams than those founded solely by women.
read more
 
Share: Email LinkedIn Twitter Facebook
 
Mood on healthcare PE deals muted at JP Morgan conference
(Christoph Burgstedt/Getty Images)
PitchBook lead healthcare analyst Rebecca Springer reports that the mood around private equity deals has been muted at JP Morgan's healthcare conference.

Our analysts have predicted that PE healthcare dealmaking will not return in earnest until the Federal Reserve materially cuts rates. Cocktail-hour conversations support this thesis.

Although a few platform companies are being shopped, many are using the conference to test the waters with potential buyers, looking at a late 2024 or 2025 transaction. When larger deals do resume, platforms may trade at EBITDA multiples significantly below 2021 rates.

For a full recap of the key announcements and themes at this week’s conference, register for our recap webinar at 11 a.m. PST/2 p.m. EST today.
Share: Email LinkedIn Twitter Facebook
Semiconductor companies taking generative AI cake
As the use of generative AI rippled out in 2023, infrastructure companies outperformed their peers in the public AI and machine learning cohort. AI semiconductor companies, especially, benefited from the new trend, with median share price increases of 71% for the year.

Our Q4 2023 Artificial Intelligence & Machine Learning Public Comp Sheet and Valuation Guide tracks stock performance, valuations, market caps, revenue and EBITDA data for key publicly traded companies.
see the data
 
Share: Email LinkedIn Twitter Facebook
Auto commerce's stellar returns lead for public mobility tech companies
Performance of public companies in the electric vehicle industry slowed overall in Q4, but fortunes differed across other segments of the mobility tech sector. In total for 2023, Carvana's shares rocketed up 1,090%, leading the way for overall auto commerce returns to shoot up 149%.

Our Q4 2023 Mobility Tech Public Comp Sheet and Valuation Guide tracks stock performance, valuations and market caps—as well as forecasts for revenue, EBITDA and earnings per share—for key publicly traded companies.
see the data
 
Share: Email LinkedIn Twitter Facebook
Creativity will be key to PE's success in 2024
(Joey Schaffer/PitchBook News)
Ingenuity and adaptability have always been in private equity's DNA. But 2023 was a year when the paradigm shifted dramatically, and PE had little option but to change up its approach.

The coming year is likely to bring greater stability, but there is little indication that dramatic changes in market conditions are in the offing. Creative approaches will be key.

So which of 2023's nascent trends should we watch this year? Secondaries, NAV financing, growth investing and carveout deals are just a few things to keep an eye on.
read more
 
Share: Email LinkedIn Twitter Facebook
 
Since yesterday, the PitchBook Platform added:
12
VC valuations
2185
People
832
Companies
29
Funds
See what our data software can do
 
The Daily Benchmark:
2016 Vintage US PE Funds
Median IRR
21.53%
Top Quartile IRR
27.33%
0.91x
Median DPI
Select top performers
Francisco Agility Fund
Renovus Capital Partners II
Gemspring Capital Fund I
*IRR: net of fees
88 Funds in Benchmark »
Check out the latest version of PitchBook Benchmarks
 
VC Deals  
Amsterdam-based online grocer Picnic has raised €355 million from investors including The Bill and Melinda Gates Foundation and Edeka.

Ji Xing Pharmaceuticals, a Shanghai-based clinical-stage biotech company, has raised $162 million from Bayer, which invested $35 million, and RTW Investments, which invested $127 million.

Digital blogging and social media company Quora has raised $75 million from Andreessen Horowitz to accelerate its AI chatbot development.

Nalu Medical, a medtech device company for chronic neuropathic pain, has raised a $65 million Series E led by Novo Holdings.

French AI-powered image editing company PhotoRoom is nearing a deal for between $50 and $60 million led by Balderton Capital, TechCrunch reported.

Milan-based Contents.com has secured an $18 million Series B led by Alkemia Capital and Thomson Reuters Ventures for its AI content generation platform.

Sqim, an Italian developer of natural materials using mycelium, has secured €11 million from investors including CDP Venture Capital, Kering Ventures, and ECBF VC.

Berlin-based micromobility startup Tier has agreed to combine operations with Amsterdam-based peer Dott. The deal is led by Tier backer Mubadala and Dott investor Sofina, which will invest €60 million in the joint business.
 
PitchBook webinar: J.P. Morgan Healthcare 2024 recap
Join PitchBook's healthcare analyst team live in San Francisco for a recap of the J.P. Morgan Healthcare Conference and a look at what's in store for the year ahead. Our team will dive deep into the most important takeaways from private company presentations, conference floor discussions, and the industry context behind the conference's biggest press releases. Topics include:
  • Private companies to watch in 2024.

  • Can't-miss announcements and what they mean for the healthcare private markets ecosystem.

  • Key emerging trends across the industry, from services to digital health to biopharma.
Register now to secure your spot.
Share: Email LinkedIn Twitter Facebook
 
PE Deals  
CVC Capital Partners is nearing a deal to acquire German vitamin and supplement company Sunday Natural, valuing it at around €900 million, Bloomberg reported.

Battery storage developer NineDot Energy secured a $225 million commitment from Manulife Investment Management and existing investor The Carlyle Group. Manulife committed $135 million and acquired an equity interest in the company.

Strategic Value Partners acquired the remaining 40% of fintech specialist IPC Systems that it did not already own.

Aquiline Capital Partners made a growth investment in LeaseCrunch, a North American lease accounting and management software company.

TA Associates made a strategic investment in CSI, a financial software and technology company.

Ambienta acquired The Rent Company. The Netherlands-based business loans out laptops and other devices to students.
 
Exits & IPOs  
UK-based firm Bluegem sold Dr. Vranjes Firenze, a home fragrance brand, to L'Occitane Group.
 
Fundraising  
EIB Global committed $30 million to Seedstars Africa Ventures' debut fund. The vehicle has a target of between $80 million and $100 million and will be used for early-stage investments.
 
Chart of the Day  
"We believe that a substantial rate-cutting cycle will be the key impetus for the resumption of platform trades. Valuations have already come down a few turns (if not more) in most healthcare services categories, and sellers need to believe that they are exiting into the best market they can reasonably hope for."

Source: PitchBook's 2024 Healthcare Outlook
 
About PitchBook | Terms of use | Advertise with us | Contact
Follow us: in twtr fb

This email was sent to you via the PitchBook Platform.

Do you want to change your email address, get a different edition or unsubscribe? Manage your subscription here.

PitchBook Data Inc., 901 Fifth Avenue, Suite 1200, Seattle WA 98164, United States

© 2024 PitchBook. Win what's next. All rights reserved.

Older messages

Coinbase leads VC's crypto retreat

Tuesday, January 9, 2024

Obesity drug market's future in focus; mobility tech's fossil-free revolution; mapping France's muted VC ecosystem; Thrive Capital targets $3B fund Read online | Don't want to receive

3 VC sectors feel extra pressure for returns

Monday, January 8, 2024

Carbon recycling offers sustainable investments; Vico Therapeutics secures $60M Series B; TCG Crossover wraps up $1B second fund Read online | Don't want to receive these emails? Manage your

PE needs to get creative in 2024

Sunday, January 7, 2024

Plus: A first look at the PitchBook-NVCA Venture Monitor, semiconductors lose luster with VC, a liquidity crunch & more Read online | Don't want to receive these emails? Manage your

A first look at 2023 VC data

Saturday, January 6, 2024

Also: December performance across the global markets; Diving into VC-backed IPO opportunities by vertical; Tech research on semiconductor scale-ups... Read online | Don't want to receive these

Gen AI services startups find a niche

Friday, January 5, 2024

December's equity, debt and commodities trends; ranking European VC's top investors; OnCusp Therapeutics rakes in $100M Read online | Don't want to receive these emails? Manage your

You Might Also Like

🚨 We’re Going LIVE! 🚨Ask Me Anything B2B Marketing is Starting

Monday, September 16, 2024

Here Is The Link To Join! ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌

🎙️ Free Webinar Tomorrow: Get Expert B2B Marketing Advice

Monday, September 16, 2024

🚨 Free Webinar Tomorrow! Last Chance To RSVP! ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌

The $200/day Facebook side hustle...

Monday, September 16, 2024

A couple years ago, I never would have thought I'd be making money directly on Facebook, through the performance bonus program. However, at the beginning of this month, I've been making nearly

SEC Drops Term ‘Crypto Asset Securities’ in Binance Case

Monday, September 16, 2024

September 16, 2024 | Read Online SEC Drops Term 'Crypto Asset Securities' in Binance Case Plus Markets Price in Jumbo 50bps Rate Cut for Fed Meeting fb fb fb fb The Breakdown First Five -

What do you do when your product launch fails? [Roundup]

Monday, September 16, 2024

Hey Reader, If you've sold on Amazon for a while, you'll (inevitably) learn that products get old fast. Either you run out of stock and sales aren't what it used to be or product sales just

What channels move the needle for agencies

Monday, September 16, 2024

How agencies are aligning marketing strategies with consumer behavior ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌

All Eyes On The Federal Reserve This Week

Monday, September 16, 2024

Today's letter is brought to you by Domain Money! ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏

Prompting with AI templates

Monday, September 16, 2024

Today's Guide to the Marketing Jungle from Social Media Examiner... Presented by social-media-marketing-world-logo It's National Collect Rocks Day, Reader... Go fill those pockets! In

Behind Mr. Ballen’s true crime kingdom 💀

Monday, September 16, 2024

The man. The myth. And his 8-figure business. Trends logo If you don't love emotional rollercoasters with missing persons, murder mysteries, and macabre intentions on otherwise quiet commutes,

Huntress secures revenue milestone

Monday, September 16, 2024

Mid-market deals spark revival; checking up on healthcare funds; VC dealmaking for India's unicorns stalls Don't want to receive these emails? Manage your subscription. Log in The Daily Pitch: